RE: As it's quiet22 Sep 2022 10:52
What we are expecting in the update:
Provexis FF sales update, new customers, global customers, distributors etc.
Factory scale-up to meet higher demand forecast.
FF+ combination products, and it is currently in dialogue with some other potential international direct selling customers.
FF + O3 Chinese distributor progress
FF + Nitrates launch progress
FF+ Subscriber numbers
DSM Progress with commercialisation of FF as a Gut Health ingredient (Hologram Sciences?)
DSM Progress with sales of FF as part of premix solutions
BH progress with the remaining 3 studies and submission to SAMR
Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow® be used as an antiplatelet regime?
Development of a new ‘contrabiotic’ polysaccharide which show efficacy against pathogens such as E coli, C difficile and S typhimurium.
Chrohn’s disease IP development options
Revenue growth +/-
Current funding situation and future financial forecast